About BaseLaunch
The BaseLaunch accelerator supports carefully selected ventures over the course of 15 months and runs in two phases. It provides non-dilutive funding, no strings attached access to its Healthcare Partners, knowledge from highly experienced advisors, as well as a state-of-the-art infrastructure. Furthermore, Baselaunch embeds the ventures deeply within the Basel region, one of Europe’s finest biotech ecosystem. Baselaunch is backed by five industry leaders — Johnson & Johnson Innovation, Novartis Venture Fund, Pfizer, Roche and Roivant Sciences — as well as by other public and private partners.
Investment Details
Investment Range
Not specified
Investment Stage
Various stages
Industry Focus
Biotechnology, Climate, Cloud (+3 more)
Investor Type
Accelerator, Venture Capital
Investment Focus
Focus Areas
Investment Stages